Dexmedetomidine and clonidine in ultrasound guided sciatic nerve block

Dexmedetomidine and clonidine as an adjuvant to levobupivacaine in ultrasound guided sciatic nerve block: A randomized, controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201604001564996

Enrollment

Registered

2016-04-04

Start date

2013-02-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Levobupivacine

Levobupivacaine plud Dexmedetomidine

Levobupivacaine plus Clonidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Above 18 years old. ASA I, II and III. Undergoing elective lower limb surgery.

Exclusion criteria

Exclusion criteria: Coagulation disorders or on anticoagulant therapy. Patients with local skin infection at the side of injection. Patients with psychosis or dementia. Patients with known allergy to one of the used drugs. Patients with neurologic or neuromuscular disorder. Morbid obesity

Design outcomes

Primary

Measure	Time frame
Duration of sensory block	—

Secondary

Measure	Time frame
Onset of sensory block ;Onset of motor block;Duration of motor block;Hemodynamic parameters (Mean arterial blood pressure, heart rate)	—

Countries

Egypt

Contacts

Public ContactSaad Ibrahim Saad

Professor of anesthesia and ICU

saadibrahim_7@yahoo.com+201223142889

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026